We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1101
Joby Aviation
JOBY
$4.59B
| $3K | ﹤0.01% |
475
| – | – |
2023 Q3
1 quarter
|
|
1102
DELISTED
ODP
ODP
| $3K | ﹤0.01% |
44
| – | – |
2022 Q1
7 quarters
|
|
1103
SS&C Technologies
SSNC
$19.9B
| $3K | ﹤0.01% |
43
| – | – |
2022 Q1
7 quarters
|
|
1104
Teladoc Health
TDOC
$1.04B
| $3K | ﹤0.01% |
+150
| New | +$2.77K |
2023 Q4
0 quarters
|
|
1105
Tilray
TLRY
$448M
| $3K | ﹤0.01% |
112
| – | – |
2022 Q1
7 quarters
|
|
1106
DELISTED
Webster Financial Corp 6.50% Series G Preferred Stock
WBS.PRG
| $3K | ﹤0.01% |
150
| – | – |
2022 Q1
7 quarters
|
|
1107
Wrap Technologies
WRAP
$80.9M
| $3K | ﹤0.01% |
900
| – | – |
2023 Q2
2 quarters
|
|
1108
Whitehawk Therapeutics
WHWK
$172M
| $3K | ﹤0.01% |
1,333
| – | – |
2022 Q3
5 quarters
|
|
|
LTRE
1109
DELISTED
LEARNING TREE INTL INC
LTRE
| $3K | ﹤0.01% |
15,340
| – | – |
2018 Q4
20 quarters
|
|
|
NWBO
1110
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
| $3K | ﹤0.01% |
4,292
| – | – |
2022 Q1
7 quarters
|
|
1111
ARK Innovation ETF
ARKK
$6.2B
| $2K | ﹤0.01% |
30
| – | – |
2022 Q1
7 quarters
|
|
1112
Array Technologies
ARRY
$502M
| $2K | ﹤0.01% |
+100
| New | +$1.72K |
2023 Q4
0 quarters
|
|
1113
DELISTED
Avanos Medical
AVNS
| $2K | ﹤0.01% |
87
-125
| -59% | -$2.58K |
2022 Q1
7 quarters
|
|
1114
Bank of America Series L
BAC.PRL
$3.6B
| $2K | ﹤0.01% |
+2
| New | +$2.23K |
2022 Q1
7 quarters
|
|
1115
Bunge Global
BG
$19.8B
| $2K | ﹤0.01% |
20
| – | – |
2023 Q3
1 quarter
|
|
1116
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$51.2B
| $2K | ﹤0.01% |
21
| – | – |
2022 Q1
7 quarters
|
|
1117
Beyond Meat
BYND
$113M
| $2K | ﹤0.01% |
+8
| New | +$1.89K |
2023 Q4
0 quarters
|
|
1118
Cannae Holdings
CNNE
$688M
| $2K | ﹤0.01% |
+100
| New | +$1.82K |
2023 Q4
0 quarters
|
|
1119
Coty
COTY
$2.81B
| $2K | ﹤0.01% |
190
-2,000
| -91% | -$21.6K |
2023 Q2
2 quarters
|
|
1120
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.95B
| $2K | ﹤0.01% |
75
| – | – |
2023 Q1
3 quarters
|
|
1121
Eaton Vance Limited Duration Income Fund
EVV
$967M
| $2K | ﹤0.01% |
255
| – | – |
2022 Q1
7 quarters
|
|
1122
DELISTED
Hanesbrands
HBI
| $2K | ﹤0.01% |
434
| – | – |
2022 Q1
7 quarters
|
|
1123
Honda
HMC
$44.2B
| $2K | ﹤0.01% |
50
| – | – |
2022 Q1
7 quarters
|
|
1124
International Flavors & Fragrances
IFF
$23.2B
| $2K | ﹤0.01% |
23
| – | – |
2022 Q1
7 quarters
|
|
1125
iShares Russell Top 200 Growth ETF
IWY
$16.3B
| $2K | ﹤0.01% |
13
| – | – |
2022 Q1
7 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.